ISPE releases guidance for standardising use of booklet labels

Published: 4-Apr-2013
Packaging Regulatory

To help companies conducting clinical trials in multiple countries


ISPE, the Tampa, Florida, US-based International Society for Pharmaceutical Engineering, has published guidance to help companies conducting clinical trials in multiple countries standardise their use of booklet labels.

The guide provides templates, guidelines and tools to make it easier for companies to use booklet labels consistently and effectively and justify their labelling methods to international regulatory authorities.

“Companies involved in clinical trials now have a resource that provides guidance on how to design and structure a booklet label and how to standardise the use and application of booklet labels for global clinical trials,” said ISPE President and CEO Nancy Berg.

“By following the recommendations presented in the guide, companies can feel confident that their booklet label strategy is supported by a scientific, risk-based methodology and patients are receiving accurate, complete instructions in their local language.”

MHRA officials in the UK have reviewed The ISPE Good Practice Guide: Booklet Labels and their feedback has been incorporated into the publication. ISPE says the recommendations will help companies determine the gaps between their current booklet label procedures and best practices. The guide contains resources for training clinical trial personnel on proper booklet label use and templates that companies can put into practice immediately to help improve compliance and cost-effectiveness of their clinical trials.

  • Companies:
  • International Society for Pharmaceutical Engineering
See more

You may also like

Regulatory

PDA and ISPE publish guide to finding root cause of quality failure

Read more
The organisations have also announced that they have signed a MOU confirming their plans to continue to advance practical approaches for quality culture

Trending Articles

  1. The right validation model: practical considerations and applications It is widely accepted that validation in the life sciences industry follows a lifecycle model (1,2). What is not always clear is the specific model — or models — to follow and how to navigate through them in the real world. Hurdles to overcome include the specific deliverables that make up that model and how they change during the various interactions along the validation journey
  2. Bayer's acoramidis recommended for approval by the EMA's CHMP for cardiomyopathy The orally administered transthyretin (TTR) stabiliser is suitable for patients with transthyretin amyloid cardiomyopathy, demonstrating at least a 90% TTR stabilisation capacity and a reduction in cardiovascular-related hospitalisations
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Merck jumps on the GLP-1 therapeutic bandwagon by licensing Hansoh Pharma's HS-10535 Merck will be responsible for the development, manufacture and commercialisation of the investigational preclinical oral GLP-1 receptor agonist
  4. Primary packaging container considerations for GLP-1-based drugs This article reviews trends related to GLP-1-type pharmaceuticals and discusses considerations for fill-and-finish and primary packaging containers
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Why quality control should be intimately combined with sterile product development, manufacturing and the overall product supply chain With sponsor companies increasingly needing to create and launch differentiated, stable, usable and safe injectable treatments for patients, experts at ten23 health are keen to promote the importance of integrating development and/or manufacturing with quality control services

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

PDA and ISPE publish guide to finding root cause of quality failure

The organisations have also announced that they have signed a MOU confirming their plans to continue to advance practical approaches for quality culture
Regulatory

ISPE releases the new Cultural Excellence Report

Report concentrates on Leadership and Vision, Mindset and Attitudes, Gemba Walk, Leading Quality Indicators and Triggers, Oversight and Review and Structural Enablers
You need to be a subscriber to read this article.
Click here to find out more.
Regulatory

Complex drugs take up more QA resource

Quality Assurance not only requires increasing resource but also needs to be introduced at an increasingly early stage of development. Susan Birks reports on trends, regulatory changes and issues affecting quality programmes
Regulatory

ISPE launches plan to prevent drug shortages

Experts collaborate to help keep quality medicines available to those who need them
Regulatory

ISPE releases first look at its plan to prevent drug shortages

Aimed at helping the pharmaceutical industry avoid drug shortages and maintain a robust and reliable supply of medications to patients world-wide
Regulatory

ISPE updates and expands guidance for testing of GxP systems

Conforms to GAMP 5 concepts and terminology
Regulatory

ISPE updates water and steam systems guide

Addresses changes to industrial practices and global regulations
Subscribe now